An epigenetic vaccine model active in the prevention and treatment of melanoma
<p>Abstract</p> <p>Background</p> <p>Numerous immune genes are epigenetically silenced in tumor cells and agents such as histone deacetylase inhibitors (HDACi), which reverse these effects, could potentially be used to develop therapeutic vaccines. The conversion of can...
Main Authors: | Magner William J, Khan A Nazmul H, Tomasi Thomas B |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-12-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/5/1/64 |
Similar Items
-
Targeting Epigenetic Modifications in Uveal Melanoma
by: Pooneh Chokhachi Baradaran, et al.
Published: (2020-07-01) -
Epigenetic Regulation in Melanoma: Facts and Hopes
by: Emilio Francesco Giunta, et al.
Published: (2021-08-01) -
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
by: Ernesto Rossi, et al.
Published: (2019-10-01) -
Epigenetics, prospects for the prevention and treatment of common diseases
by: Enelis Reyes-Reyes, et al.
Published: (2018-04-01) -
Bioinformatics analysis of epigenetic variants associated with melanoma
by: Murat, Katarzyna
Published: (2019)